Dr. Sherman Hom is the Director of Regulatory Affairs at Medicinal Genomics where he provides recommendations to regulatory officials that are tasked with drafting or modifying microbial testing regulations for cannabis, hemp, and psychedelic mushrooms to ensure safe products for patients and consumers. Before Medicinal Genomics, he was at the New Jersey Department of Health, where he led teams that started the Cannabis Testing Laboratory, the Cannabis Microbial Testing Unit, and created the “All States Medical Cannabis Program Required Testing Compendium”.
At CannMed 23 Sherman will share the latest update to the “All States Cannabis Microbial Required Testing Compendium” to elucidate the present landscape, and identify a consensus set of required tests to lower public health risk.
During our conversation we discuss
- How concerned cannabis consumers should be about microbial contamination
- How microbial regulations differ from state to state
- How growers in certain jurisdictions struggle to meet microbial regulations
- The difference between presence-absence and total count microbial tests
- qPCR vs plating
- and more
Thanks to This Episode’s Sponsor: Labware
Labware is recognized as the global leader in providing enterprise-scale laboratory automation solutions with over 40 offices across 6 continents. LabWare’s Enterprise Laboratory Platform is a unique and proven suite of product capabilities that encompass LIMS, ELN, LES, method execution, and SDMS in an integrated and enterprise-ready solution.
Learn more at labware.com.
Additional Resources
Cannabis Microbial Testing Regulations by State [Interactive Tool] - [ Ссылка ]
Request an Invitation to CannMed 23 - [ Ссылка ]
Review the Podcast! - [ Ссылка ]
CannMed Archive - [ Ссылка ]
